Cerrado Gold is a Toronto-based gold production, development, and exploration company. The Company is the 100% owner of the producing Minera Don Nicolás and Las Calandrias mine in Santa Cruz province, Argentina. In Portugal, the Company holds an 80% interest in the highly prospective Lagoa Salgada VMS project through its position in Redcorp - Empreendimentos Mineiros, Lda. In Canada, Cerrado Gold is developing its 100% owned Mont Sorcier Iron project located outside of Chibougamou, Quebec.

In Argentina, Cerrado is maximizing asset value at its Minera Don Nicolas operation through continued operational optimization and is growing production through its operations at the Las Calandrias heap leach project. An extensive campaign of exploration is ongoing to further unlock potential resources in our highly prospective land package in the heart of the Deseado Masiff.

In Portugal, Cerrado focused on the exploration and development of the highly prospective Lagoa Salgada VMS project located on the prolific Iberian Pyrite Belt in Portugal. The Lagoa Salgada project is a high-grade polymetallic project, demonstrating a typical mineralization endowment of zinc, copper, lead, tin, silver, and gold. Extensive exploration upside potential lies both near deposit and at prospective step-out targets across the large 7,209-hectare property concession. Located just 80km from Lisbon and surrounded by exceptional infrastructure, Lagoa Salgada offers a low-cost entry to a significant exploration and development opportunity, already showing its mineable scale and cashflow generation potential.

Cobalt Blue Holdings Limited is an Australian mining and minerals processing company developing an integrated critical minerals platform spanning resource development, refining and technology innovation. The Company’s strategy is designed to strengthen and diversify global supply chains in partnership with like-minded countries.

Curatis Holding AG (SIX: CURN) is a Switzerland-based specialty pharmaceutical company focused on the late-stage development and commercialization of medicines for rare diseases and specialty care. The company operates through two complementary business areas: the distribution and promotion of specialty and orphan drugs, and the development of its own pipeline of novel therapies addressing areas of high unmet medical need. Curatis currently markets a portfolio of approximately 50 products and is advancing a pipeline of orphan and specialty drug candidates, with a development strategy focused on compounds with existing safety and clinical efficacy data to potentially reduce development risk and accelerate commercialization.

Deep Isolation (OTCQB: DBHL) is the first company to undertake development of technologies for nuclear waste disposal in deep boreholes. When commercialized, Deep Isolation’s solution will offer a unique approach to help countries identify, plan for and complete the necessary steps to dispose of their nuclear waste inventories. With over 100 patents issued to date, Deep Isolation’s technology is being designed to leverage proven drilling practices to allow safe isolation of waste deep underground in horizontal, vertical, or slanted borehole repositories. Deep Isolation’s Universal Canister System was developed through a three-year project funded by the U.S. Department of Energy’s Advanced Research Projects Agency–Energy and is engineered to support integrated management of spent fuel and high-level radioactive waste from legacy and advanced reactors across storage, transportation, and eventual disposal. In January 2026, Deep Isolation launched a full-scale, at-depth deep borehole Commercialization Pilot for its solution at Cameron, Texas, in collaboration with the Deep Borehole Demonstration Center, Halliburton (NYSE: HAL), Amentum (NYSE: AMTM), NAC International (TYO: 7004), and Occlusion Nuclear Solutions.

Delta Gold Technologies is developing a portfolio of intellectual property focused on the application of nano-scale gold and other advanced materials in quantum information science, including quantum computing, quantum sensing and quantum communication. The Company's research programmes are being conducted in collaboration with leading academic institutions, including The Pennsylvania State University and the University of Toronto, under sponsored research arrangements. The Company has secured rights to intellectual property arising from these programmes, including patent applications filed by Penn State and University of Toronto and continues to support additional research and patent development across its academic collaborations. The Company's strategy is to develop, protect and commercialise novel quantum materials technologies through patent protection, licensing arrangements and strategic partnerships.

The Swiss-based DocMorris AG is a leading company in the fields of online pharmacy, telemedicine and marketplace with strong brands in Germany and other European countries. Deliveries are mainly from the highly automated logistics centre in Heerlen, the Netherlands. TeleClinic is Germany’s largest telemedicine platform, connecting patients with more than 6,500 physicians. DocMorris operates leading marketplaces for health and personal care products in Southern Europe. With its broad range of products and services, DocMorris is pursuing its vision of becoming the leading digital health companion for everyone to manage their health in one click. Around 1,600 employees in Germany, the Netherlands, Spain, France, Portugal and Switzerland generated an external revenue of CHF 1,186 million serving more than 12 million active customers in 2025. The shares of DocMorris AG are listed on the SIX Swiss Exchange (securities number 4261528, ISIN CH0042615283, ticker DOCM). For further information, please visit corporate.docmorris.com.

First Class Metals PLC (LSE: FCM) is a UK-listed mineral exploration company focused on the discovery and development of gold and critical metal deposits in Ontario, Canada. The company holds a diversified portfolio of exploration properties across highly prospective geological belts, with flagship gold projects at North Hemlo and Sunbeam, alongside exposure to nickel, copper, molybdenum, lithium and other critical minerals. First Class Metals employs a disciplined, data-driven exploration strategy aimed at advancing high-potential projects and creating value through mineral discovery and asset development.

First Phosphate (CSE: PHOS) (OTCQX: FRSPF) (OTCQX ADR: FPHOY) (FSE: KD0) is a mineral exploration and development and clean technology company dedicated to building and reshoring a vertically integrated mine-to-market supply chain for the production of LFP batteries in North America. Target markets include energy storage, data centers, robotics, mobility, and national security.

First Phosphate's flagship Bégin-Lamarche property, located in Saguenay-Lac-Saint-Jean, Québec, Canada, represents a rare North American igneous phosphate resource producing high-purity phosphate characterized by very low levels of impurities.

Good Purpose Investments Inc. is a sustainability-focused company that acquires, develops, and scales environmentally aligned businesses operating across circular materials, sustainable manufacturing technologies, and next-generation consumer product categories. The Company aims to build a diversified portfolio of investments and internally developed businesses supported by shared infrastructure, commercial expertise, and centralized innovation capabilities. Its initial portfolio company is Waste2Wear, a wholly owned subsidiary of GPI and provider of circular textile and product solutions.

Kuya Silver is a Canadian‐based, growth-oriented mining company with a focus on silver. Kuya Silver operates the Bethania silver mine in Peru, while developing district-scale silver projects in mining-friendly jurisdictions including Peru, Canada and Saudi Arabia.

Making Science is a marketing and technology consultancy that helps companies accelerate their digital capabilities with Artificial Intelligence. We have more than 800 employees with a direct presence and technological development in 18 markets, and in another 10 through partnerships.

MetaOptics Ltd (Catalist: 9MT) is a leading-edge semiconductor optics company pioneering glass-based metalens solutions enhanced by AI-driven image processing. Using advanced optical design and a scalable 12-inch DUV lithography process, it powers next-generation applications in CPO, mobile, AR VR, automotive and other emerging markets. Headquartered in Singapore, MetaOptics aims to deliver high-performance optics with the reliability and scalability demanded by today's most innovative technology brands. Find out more at www.metaoptics.sg.

MindMaze Therapeutics is a Swiss-based, commercial-stage company formed in December 2025 through the business combination of RELIEF THERAPEUTICS Holding SA (Relief) and NeuroX Group SA. The Company develops and commercializes first-of-its-kind digital treatments for neurological diseases and brain disorders. Built on an advanced brain technology platform integrating software, sensors, and telehealth, its solutions are deployed globally across clinics and home settings. MindMaze Therapeutics' clinically validated neurotherapeutics have demonstrated significant medico-economic outcomes across conditions such as stroke, Parkinson's disease, and at-risk aging. The Company continues to expand its R&D pipeline into adjacent neurological indications, including multiple sclerosis, spinal cord injury, traumatic brain injury, and Alzheimer's disease.

The Company also manages Relief's preexisting portfolio of clinical and commercial biopharmaceutical assets focused on rare dermatological, metabolic, and respiratory diseases.

Nouveau Monde Graphite is an integrated company developing responsible mining and advanced manufacturing operations to supply the global economy with carbon-neutral active anode material to power. The battery, energy, advanced technologies and manufacturing markets. The Company is developing a fully integrated ore-to-battery-material source of graphite-based active anode material in Québec, Canada. With recognized ESG standards and structuring partnerships with anchor customers, NMG is set to become a strategic supplier to the world’s leading lithium-ion battery and EV manufacturers, providing advanced materials while promoting sustainability and supply chain traceability. www.NMG.com

Oryzon Genomics SA is a clinical-stage biopharmaceutical company and a European leader in the development of epigenetics-based therapeutics. The company is advancing a pipeline of internally developed drug candidates focused primarily on central nervous system disorders, oncology and hematology, with two lead compounds in clinical development. Oryzon has offices in Spain and the United States.

In a world where health is becoming increasingly complex, REIG JOFRE has a clear purpose: to universalize the solutions that truly matter to people. This commitment is not merely a statement of intent — it is the driving force that defines our path, our decisions, and our ambition as a company. We transform basic and rational science into applied and human science, bringing it from the laboratory into everyday life — developing, producing, distributing, and marketing essential health solutions that range from prevention and well-being to the most critical and specialized treatments, in every corner of the world.

SulNOx Group PLC develops and supplies patented, 100% organic fuel conditioners that improve combustion in all liquid hydrocarbon fuels.

Its drop-in solutions help reduce fuel costs and emissions without requiring any capital investment or operational change. Proven in over 40 countries and protected by patents in more than 50, the technology supports cleaner, more efficient fuel use across sectors such as marine, mining and transport.